Isoflurane in the Aged Brain: A Link to Altered Amyloid Precursor Protein Processing
Journal Title: Journal of Parkinson’s Disease and Alzheimer’s Disease - Year 2015, Vol 2, Issue 2
Abstract
General anaesthesia can cause an altered mental status, particularly in elderly patients. While these changes usually represent a temporary, reversible delirium, there is growing, but still inconclusive evidence that suggests isoflurane can induce changes to key neurodegenerative proteins such as the amyloid precursor protein and its processed fragment, amyloid beta peptide. To further characterize the conditions under which such changes may take place, we have undertaken a preliminary study in which 17-month-old C57/Bl6 mice were exposed to two anaesthetic regimens. One cohort was treated with 1% isoflurane for 6 hours (acute); the second cohort was treated with 1.4% isoflurane for 2 hours per day for five consecutive days (chronic). Brain homogenates were analysed by western blotting. An acute exposure significantly altered processing of full-length amyloid precursor protein with a reduction in its soluble levels (-22%, p< 0.05), while there was a concomitant increase in levels of its processed fragments; 81% (p< 0.05) for a 60 kDa fragment and 32% (p< 0.05) for a 40 kDa fragment. There were fewer effects from a chronic exposure, with membrane levels of amyloid precursor protein decreasing (-17%, p< 0.05). These findings suggest that an acute exposure to isoflurane can lead to in vivo changes to key pathways involved in the development of Alzheimer’s disease.
Authors and Affiliations
Paul A. Adlard
Keywords
Related Articles
- EP ID EP207474
- DOI 10.13188/2376-922X
- Views 134
- Downloads 0
The Role of Cerebrovascular Disease in Parkinson’s Disease Related Cognitive Impairment
With the high prevalence rate of mild cognitive impairment (MCI) and dementia in Parkinson’s disease (PD), there is an increasing need to establish biomarkers that could identify those at risk of dementia. Small vessel c...
Dihydrolipoic Acid Conjugated Carbon Dots Accelerate Human Insulin Fibrillation
Protein fibrillation is believed to play an important role in the pathology and development of several human diseases, such as Alzheimer’s disease, Parkinson’s disease, and type 2 diabetes. Carbon dots (CDs), as a new ty...
Therapeutic Advantages of Dual Targeting of PPAR-δ and PPAR-γ in an Experimental Model of Sporadic Alzheimer’s Disease
Background: Alzheimer’s disease (AD) is associated with progressive impairments in brain responsiveness to insulin and insulinlike growth factor (IGF). Although deficiencies in brain insulin and IGF could be ameliorated...
Alzheimer’s Disease: AdultOnset of Inborn Error of Methionine Metabolism
The cause and treatment of Alzheimer’s Disease remains obscure. It could arise from adult onset of an inborn error of metabolism of the essential amino acid methionine expressed through an alternate biochemical pathway f...
Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD
Compared to the rare familial early onset Alzheimer’s disease (AD) that results from gene mutations in AbPP and presenilin-1, the pathogenesis of sporadic AD is much more complex and is believed to result from complex in...